ストックスクリーナーアプリを入手
1.11
0.00%
0.00
アフターアワーズ：
1.14
0.03
+2.70%
前日終値:
$1.11
開ける：
$1.18
24時間の取引高:
533.64K
Relative Volume:
1.73
時価総額：
$6.25M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+7.77%
1か月 パフォーマンス:
-10.48%
6か月 パフォーマンス:
-72.39%
1年 パフォーマンス:
-78.86%
1日の値動き範囲:
$1.03
$1.22
1週間の範囲:
$0.8563
$1.22
52週間の値動き範囲:
$0.8563
$5.88
Callan Jmb Inc Stock (CJMB) Company Profile
Compare CJMB vs FDX, UPS, JBHT, CHRW, EXPD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CJMB
Callan Jmb Inc
|
1.11 | 6.25M | 0 | 0 | 0 | 0.00 |
FDX
Fedex Corp
|
393.67 | 93.11B | 91.93B | 4.48B | 4.37B | 18.79 |
UPS
United Parcel Service Inc
|
107.57 | 88.32B | 88.64B | 5.57B | 4.77B | 6.5569 |
JBHT
J B Hunt Transport Services Inc
|
248.73 | 23.70B | 12.13B | 622.10M | 1.03B | 6.4596 |
CHRW
C H Robinson Worldwide Inc
|
177.30 | 22.15B | 16.20B | 599.01M | 807.11M | 4.9434 |
EXPD
Expeditors International Of Washington Inc
|
147.23 | 19.60B | 11.07B | 812.05M | 953.40M | 5.9494 |
Callan Jmb Inc (CJMB) 最新ニュース
Callan JMB (CJMB) Stock: Why Revenue Growth (Institutional Demand) 2026-04-22Shared Trade Alerts - Newser
CJMB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Callan JMB Inc. plans 150-acre campus in Marion - Business Alabama Magazine
Callan JMB plans 150-acre pharmaceutical campus in Alabama By Investing.com - Investing.com India
Callan JMB plans 150-acre pharmaceutical campus in Alabama - Investing.com
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC - marketscreener.com
Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure - The Manila Times
Callan JMB Launches The Atlas Complex in Alabama to - GlobeNewswire
Callan JMB faces patent infringement lawsuit in Texas By Investing.com - Investing.com Australia
Callan JMB faces patent infringement lawsuit in Texas - Investing.com
Callan JMB Inc. Responds to Lawsuit Filed by Eddie Patent Holdings, LLC - Quiver Quantitative
Callan Jmb Complaint Filed By Eddie Patent Holdings Does Not Impact Operations, Strategic Partnerships, Or Ongoing Projects - TradingView
Investment Report: What drives Callan JMB Incs stock price2026 Closing Moves & Reliable Price Breakout Signals - baoquankhu1.vn
Earnings Miss: Is Callan JMB Inc stock a buy or sell2026 Intraday Action & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Callan JMB Inc. Files Form 8-K with SEC: Company Details, Address, and NASDAQ Listing Information - Minichart
Callan JMB Receives Nasdaq Deficiency Notice on Equity - TipRanks
Callan JMB Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Growth Report: Is Callan JMB Inc forming a bullish divergence2026 Winners & Losers & Technical Pattern Alert System - baoquankhu1.vn
Is Callan JMB (CJMB) Stock defensive in downturns | Price at $1.19, Down 1.65%Market Buzz Alerts - Newser
Aug Update: Does Callan JMB Inc align with a passive investing strategy2026 Outlook & Verified Swing Trading Watchlists - baoquankhu1.vn
Is Callan JMB (CJMB) Stock Moving Higher | Price at $1.29, Down 1.53%Beta Signals - Newser
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer - Sahm
Callan JMB Accelerates Cross-Jurisdiction Vaccine Redistribution to Combat Localized Outbreaks - Healthcare Packaging
Aug Momentum: What drives Callan JMB Incs stock priceMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Callan JMB Successfully Deploys Rapid Redistribution of - GlobeNewswire
New Highs: Is Xylem Inc in a long term uptrend2026 Top Decliners & AI Driven Stock Movement Reports - baoquankhu1.vn
Callan Jmb (CJMB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
CJMB Stock Analysis: Callan JMB Inc. 7.26 Percent Gain to 1.33, Key Drivers Breakdown - Cổng thông tin điện tử tỉnh Tây Ninh
Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update - The Manila Times
EV Market: What drives Callan JMB Incs stock priceIPO Watch & Verified Technical Signals - baoquankhu1.vn
Callan JMB to oversee manufacturing for JKB-122 immune platform By Investing.com - Investing.com South Africa
12 Industrials Stocks Moving In Friday's Intraday Session - Benzinga
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement - globenewswire.com
Top Executive Makes Bold Insider Move at Callan JMB, Inc. - TipRanks
Croyle David J, chief medical officer, buys $17841 in Callan JMB Inc. - Investing.com UK
Market Review: What drives Callan JMB Incs stock price2026 Rallies & Fast Moving Stock Trade Plans - baoquankhu1.vn
Volume Summary: Does Callan JMB Inc align with a passive investing strategy - baoquankhu1.vn
Callan JMB files to sell 6M shares of common stock for holders - MSN
Callan JMB Amends Equity Purchase Agreement with Hexstone - The Globe and Mail
Callan JMB to oversee manufacturing for Long COVID drug trial By Investing.com - Investing.com South Africa
Callan JMB to oversee manufacturing for Long COVID drug trial - Investing.com
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech's IND Clinical Trials for lodonal in the Treatment of Long COVID - Bitget
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID - The Globe and Mail
Croyle David J, chief medical officer, buys Callan JMB (CJMB) shares - Investing.com India
Croyle David J, chief medical officer, buys Callan JMB (CJMB) shares By Investing.com - Investing.com South Africa
Callan Jmb Inc (CJMB) 財務データ
Callan Jmb Inc (CJMB) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Callan Jmb Inc (CJMB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Croyle David J | Chief Medical Officer |
Mar 06 '26 |
Buy |
1.76 |
14,805 |
26,086 |
789,805 |
| Dial Gerald | Director |
Dec 30 '25 |
Buy |
1.20 |
2,000 |
2,409 |
2,000 |
| Williams Wayne D | CEO, Chairman and President |
Dec 16 '25 |
Buy |
1.73 |
5,000 |
8,650 |
84,355 |
| Williams Wayne D | CEO, Chairman and President |
Dec 15 '25 |
Buy |
1.70 |
10,810 |
18,377 |
79,355 |
| Williams Wayne D | CEO, Chairman and President |
Dec 12 '25 |
Buy |
1.75 |
4,926 |
8,620 |
2,267,488 |
| Williams Wayne D | CEO, Chairman and President |
Dec 11 '25 |
Buy |
1.79 |
62 |
111 |
2,262,562 |
| Williams Wayne D | CEO, Chairman and President |
Dec 11 '25 |
Buy |
1.65 |
30,856 |
50,912 |
68,545 |
| Williams Wayne D | CEO, Chairman and President |
Dec 10 '25 |
Buy |
1.65 |
13,689 |
22,587 |
38,689 |
| Duke Liberty Smith | Director |
Dec 08 '25 |
Buy |
1.56 |
900 |
1,404 |
900 |
| Duke Liberty Smith | Director |
Dec 09 '25 |
Buy |
1.52 |
612 |
930 |
1,512 |
0.45%
1.48%
大文字化:
|
ボリューム (24 時間):